Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 75.04%16.02M | 83.61%13.54M | 87.09%11.48M | 32.56%32.99M | 78.20%10.33M | 42.31%9.15M | 18.60%7.37M | -4.80%6.13M | 12.63%24.89M | -9.63%5.8M |
| Operating revenue | 75.04%16.02M | 83.61%13.54M | 87.09%11.48M | 32.56%32.99M | 78.20%10.33M | 42.31%9.15M | 18.60%7.37M | -4.80%6.13M | 12.63%24.89M | -9.63%5.8M |
| Cost of revenue | 56.62%5.85M | 59.68%5.04M | 29.69%4.18M | 9.16%13.65M | 17.78%3.53M | 25.57%3.74M | -4.28%3.16M | -0.25%3.22M | 10.39%12.5M | -3.48%3M |
| Gross profit | 87.76%10.17M | 101.54%8.5M | 150.64%7.3M | 56.18%19.34M | 142.88%6.8M | 56.73%5.42M | 44.45%4.22M | -9.37%2.91M | 14.97%12.39M | -15.40%2.8M |
| Operating expense | 117.00%9.38M | 115.17%7.49M | 118.59%6.18M | 57.78%16M | 79.40%5.37M | 59.20%4.32M | 50.65%3.48M | 33.25%2.83M | 51.96%10.14M | 56.43%2.99M |
| Selling and administrative expenses | 119.61%8.4M | 120.38%6.49M | 130.72%5.42M | 61.02%13.71M | 84.21%4.6M | 66.26%3.82M | 52.30%2.94M | 31.36%2.35M | 55.28%8.52M | 56.82%2.5M |
| -Selling and marketing expense | ---- | ---- | ---- | 83.91%846K | ---- | ---- | ---- | ---- | 39.82%460K | ---- |
| -General and administrative expense | 119.61%8.4M | 120.38%6.49M | 130.72%5.42M | 59.71%12.87M | 84.28%3.75M | 66.26%3.82M | 52.30%2.94M | 31.36%2.35M | 56.26%8.06M | 61.25%2.04M |
| Depreciation amortization depletion | 97.00%985K | 86.57%1M | 59.08%762K | 40.79%2.29M | 55.24%770K | 20.19%500K | 42.18%536K | 43.41%479K | 36.62%1.62M | 54.52%496K |
| -Depreciation and amortization | 97.00%985K | 86.57%1M | 59.08%762K | 40.79%2.29M | 55.24%770K | 20.19%500K | 42.18%536K | 43.41%479K | 36.62%1.62M | 54.52%496K |
| Operating profit | -28.14%784K | 37.01%1.01M | 1,256.10%1.11M | 48.93%3.35M | 856.32%1.44M | 47.63%1.09M | 20.89%735K | -92.47%82K | -45.22%2.25M | -113.58%-190K |
| Net non-operating interest income (expenses) | -55.53%-619K | -3.91%-531K | 18.28%-438K | -20.23%-1.95M | -7.46%-504K | 9.55%-398K | -35.90%-511K | -59.52%-536K | -52.49%-1.62M | -46.56%-469K |
| Non-operating interest income | -82.46%10K | ---- | ---- | ---- | ---- | --57K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 15.18%516K | -17.09%422K | -18.48%419K | 24.33%1.91M | -3.55%435K | 5.41%448K | 48.40%509K | 63.69%514K | 48.40%1.53M | 45.02%451K |
| Total other finance cost | 1,514.29%113K | 5,350.00%109K | -13.64%19K | -51.14%43K | -33.33%12K | -53.33%7K | -93.94%2K | 0.00%22K | 193.33%88K | 100.00%18K |
| Other net income (expenses) | 91.12%-34K | -101.35%-16K | -225.00%-52K | -88.51%233K | -175.12%-553K | -3,381.82%-383K | -47.10%1.19M | -1,500.00%-16K | 112.03%2.03M | -2,412.50%-201K |
| Gain on sale of security | ---- | 7.69%-12K | -1,250.00%-27K | -2,850.00%-55K | -233.33%-20K | -566.67%-20K | -208.33%-13K | -100.00%-2K | 102.86%2K | 73.91%-6K |
| Special income (charges) | 90.63%-34K | 97.71%-4K | -78.57%-25K | -709.70%-1.09M | -173.33%-533K | -4,437.50%-363K | -353.62%-175K | ---14K | -193.71%-134K | -1,400.00%-195K |
| -Less:Other special charges | ---- | ---- | ---- | --173K | --0 | ---- | --173K | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | -38.46%16K | ---- | ---- | ---- | ---- | 160.00%26K | ---- |
| -Gain on sale of property,plant,equipment | 90.63%-34K | -100.00%-4K | -78.57%-25K | -729.63%-896K | -205.92%-517K | -4,437.50%-363K | -102.90%-2K | ---14K | -170.59%-108K | -776.00%-169K |
| Other non-operating income (expenses) | ---- | ---- | ---- | -36.41%1.37M | --0 | ---- | -36.41%1.37M | ---- | 144.51%2.16M | --0 |
| Income before tax | -57.74%131K | -67.35%460K | 232.34%622K | -38.57%1.63M | 144.19%380K | 7.64%310K | -43.00%1.41M | -162.50%-470K | -33.58%2.65M | -180.30%-860K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -57.74%131K | -67.35%460K | 232.34%622K | -38.57%1.63M | 144.19%380K | 7.64%310K | -43.00%1.41M | -162.50%-470K | -55.79%2.65M | -127.96%-860K |
| Net income continuous operations | -57.74%131K | -67.35%460K | 232.34%622K | -38.57%1.63M | 144.19%380K | 7.64%310K | -43.00%1.41M | -162.50%-470K | -55.79%2.65M | -127.96%-860K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -57.74%131K | -67.35%460K | 232.34%622K | -38.57%1.63M | 144.19%380K | 7.64%310K | -43.00%1.41M | -162.50%-470K | -55.79%2.65M | -127.96%-860K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -57.74%131K | -67.35%460K | 232.34%622K | -38.57%1.63M | 144.19%380K | 7.64%310K | -43.00%1.41M | -162.50%-470K | -55.17%2.65M | -127.96%-860K |
| Diluted earnings per share | 0 | 0 | 200.00%0.01 | -50.00%0.02 | 200.00%0.01 | 0 | -33.33%0.02 | -200.00%-0.01 | -55.56%0.04 | -120.00%-0.01 |
| Basic earnings per share | 0 | 0 | 200.00%0.01 | -33.33%0.02 | 200.00%0.01 | 0 | -33.33%0.02 | -200.00%-0.01 | -62.50%0.03 | -125.00%-0.01 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.